Cryptate Compounds

Cryptate Compound

ANSTO's technology commercialisation opportunities include Cryptate Compounds.

About Cryptate Compounds - technology and development

Researchers at ANU and ANSTO have developed a series of bi-functional ligands that have applications for use as medical imaging agents and as radiopharmaceuticals. The technology can be complexed with a wide range of metal ions and readily adapted to a range of protein and peptide targeting molecules.

Commercial status: In development

Inventors: Suzanne Smith, John Harrowfield, Nadine Di Bartolo and Alan Saregson

ANSTO Business Development contact: Joy Woods (+61 2 9717 9009)